Objective: This study examines whether maternal group B Streptococcus (Streptococcus agalactiae, GBS) infection was associated with preterm births and premature neonatal outcomes. Methods: Maternal and neonatal outcomes were examined among singleton pregnant women with preterm birth (from 24 +0 weeks to 36 +6 weeks) who were tested for GBS (n=203) during the pregnancy. Data were collected retrospectively from the medical records of women who delivered at our hospital from January 2015 to February 2017. We compared obstetrical factors (causes of preterm birth) and neonatal (gestational age at delivery, birth weight, Apgar score 1 min/5 min, hospitaliza tion period, duration of mechanical ventilation, neonatal Creactive protein within three days, and other complication [respiratory distress syndrome, neonatal deaths]) outcomes between GBSinfect ed and noninfected pregnant women.
Introduction
Group B Streptococcus (Streptococcus agalactiae, GBS) is a Gram-positive coccus that frequently colonizes the human genital and gastrointestinal tracts, as well as the upper respiratory tract of young infants. [1] [2] [3] GBS infections in pregnant women include urinary tract infection, upper genital tract infection, intra-amniotic infection, endometritis, and bacteremia. 4, 5 Neonatal sepsis occurs in 80-85% of cases of early-onset GBS disease. 6 The mortality rate is 4-6%, and in the case of preterm birth, up to 30%. GBS can be acquired during labor or in utero by transmission from maternal-vaginal or anorectal-colonized mucosa. [7] [8] [9] In 2002, the US Centers for Disease Control and Prevention (CDC) recommended universal antenatal screening at 35 to 37 weeks of pregnancy and intrapartum chemoprophylaxis for women with GBS colonization. 10 An additional reduction in invasive GBS-related disease was reported after publication of this guideline. 6, 11 Reported maternal colonization rates are quite variable but generally range from 20% to 30%. 10, 12 The differences in colonization rates depend on the particular population and on the laboratory method used to
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Korea has not established a guideline for GBS screening during pregnancy, and there are few reports indicating a Korean interest in perinatal complications related to GBS infection in pregnant women. This lack of concern is probably due to the low GBS infection rate in Korea. Before 2010, according to national reports, the rate of GBS infection in Korean pregnant women was 0.3-5.9%. However, two recent studies reported a 2010 GBS infection rate of 8.3% or 10.0%. 13, 14 Despite major advances in perinatal care, preterm birth is still the predominant cause of perinatal mortality and a major cause of neurological morbidity in surviving infants. Although the causes of preterm birth are uncertain, evidence suggests that maternal genital tract colonization by specific organisms increases the risk of preterm rupture of membranes and preterm birth. 15 The aim of this study was to examine the relationship between maternal GBS infection and preterm birth outcomes.
Methods

Patient population
The study was approved by the institutional review board of Gachon University Gil Medical Center. The medical records of the 1,201 women admitted to our hospital for delivery between January 2015 and February 2017 were reviewed. Of the 1,201 patients, only 395 patients underwent GBS culture. Two hundred three singleton pregnant women with preterm birth (from 24 +0 weeks to 36 +6 weeks) were enrolled. One hundred ninetytwo were excluded based on exclusion criteria. The exclusion criteria were multiple pregnancies, term birth, and intrauterine fetal death of unknown cause. Cases in which the baby was transferred to another hospital were also excluded. Included in our assessments were subgroup analyses to detect differences between the two culture methods. Subgroup analysis was performed on all women who underwent GBS analysis (n=395) to examine the effect on GBS detection rate according to the culture method used. 
Data collection
Outcome definitions
Statistical analysis
To determine whether the presence of GBS statistically differed by pregnancy and neonatal outcome variables chi-
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Among the study subjects, pPROM was the most common cause of preterm birth (n=68, 56.0%). However, the incidence of SPTL was significantly higher in the GBS-negative group (P=0.005). IIOC and other causes of preterm birth were not associated with maternal GBS colonization (P>0.05) ( Table 2) . 
Discussion
Since the rate of GBS infection in Korea is considered low, there has been little apparent interest in perinatal complications associated with GBS infection in pregnant women. For this reason, Korea has not established guidelines for performing GBS screening during pregnancy. We suggest that, if multicenter medical facilities increase their level of interest in GBS infection and routinely conduct GBS analyses, the GBS diagnosis rate in Korea may increase.
In our review, 395 of 1,201 patients underwent GBS infection assessment. Thirty-eight (38/395, 9.6%) of the swab cultureassessed patients were positive for GBS. The percentage of GBS-positive patients with preterm births in the study sample was 12.3% (25/203). This incidence is higher than the infection rate previously reported in Korea but lower than that of other countries. 10, [12] [13] [14] 16 GBS prevalence and GBS serotype distribution differ by study region and country. Early-onset neonatal GBS disease has a different distribution among pregnant women in Korea than among those in other countries. 6, 17, 18 The apparent increase in GBS infection may be due to a change in serotype following changes in dietary habits and globalization. Further epidemiological studies that include large sample sizes are needed in Korea.
A CDC guideline recommends the use of rectovaginal sampling for GBS detection. 3 Based on our swab culture analysis results, after changing the GBS culture method from the use of separate vagina/rectum swabs to using a combined rectovaginal swab, the GBS detection rate increased. Previous studies have also shown that rectovaginal sampling results in an increased GBS-positive rate. 19 However, our study results have a limitation in that no comparisons were made between the two swabbing methods in the same patients.
In our study, the most common cause of preterm birth was pPROM. All patients diagnosed with pPROM were treated with antibiotics, and patients without evidence of pPROM were not treated with antibiotics. Until the vaginal culture results were available, intravenous cephalosporin injections were given to treat a broad spectrum of bacteria in pPROM patients. If the presence of GBS before delivery was confirmed, penicillin or cephalosporin treatment was applied. Treatment for GBS involves administration of penicillin intravenously every 4 hours until delivery, while cephalosporin treatment can be used for patients with a penicillin allergy. For most of our study subjects, delivery was complete before culture results were confirmed, and most patients with pPROM were treated with cephalosporin, which is not the optimal treatment for GBS infection. Failure to apply the most appropriate antibiotic for GBS is a weakness of the treatments reported in this study.
In this study, SPTL appeared to be related to GBS presence.
However, the univariate logistic analysis calculated OR was In our study, GBS infection was a risk factor for pPROM. We assume that when a maternal GBS infection occurs, it advances through an increasing abundance of GBS, eventually leading to amniotic membrane rupture.
Each of the maternal and fetal complication factors in this study was grouped and classified into two broad categories (maternal or fetal) because each of the individual factors had a small sample size and produced no statistically significant difference related to GBS infection status.
During the study period, there were 68 cases of pPROM in women with preterm births. According to the hospital protocol, all neonates born with pPROM are treated with antibiotics, usually amoxicillin. In this study, all of the neonates whose mothers were identified as GBS infected were observed for at least 24 hours for signs of sepsis and were treated with amoxicillin prophylactically. This protocol has been previously reported to prevent GBS infection and improve neonatal outcomes. 20 Perhaps this protocol was responsible for our results that GBS infection did not affect factors such as Apgar scores, hospitalization periods, duration of mechanical ventilation, RDS, and infant mortality rates in our study.
In the case of neonatal death in this study, the GBS-infected mother had a history of gestational diabetes mellitus and SPTL. She had been treated with tocolytics at 31 +5 weeks for 1 week and delivered at 34 +5 weeks. She did not receive antibiotic treatment because her GBS status was not confirmed before delivery. The newborn expired within 16 hours of birth.
Blood culture after birth revealed the presence of GBS and the neonate was diagnosed as GBS sepsis.
Ganor-Paz et al. 21 concluded that GBS carriers with pPROM do not have adverse outcomes. In Ganor-Paz's study 21 , all patients with pPROM were treated with appropriate antibiotics according to a hospital protocol. Those results suggest that complications related to GBS infection such as neonatal sepsis, neonatal infection, and a low 5 minutes Apgar score can be prevented. Based on the results of this and previous studies, further research examining pPROM in GBS carrier patients in our medical center is needed.
In conclusion maternal GBS infection in preterm birth was associated with pPROM, but it did not affect neonatal outcome.
Considering the prognosis of GBS, a major cause of neonatal sepsis and pneumonia, national GBS-related protocols are needed. Along with a GBS screening protocol, accurate screening methods and intrapartum prophylactic antibiotic administration are needed to prevent adverse neonatal outcomes in GBS-infected mothers.
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